StonvexLoading…
StonvexStonvexStonvexCore line items from FHN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $3.42B | $3.19B | $3.47B | $3.21B |
Operating Income | $1.28B | $1.00B | $1.13B | $1.16B |
Net Income | $982.00M | $775.00M | $897.00M | $900.00M |
EPS (Diluted) | $1.87 | $1.36 | $1.54 | $1.53 |
Total Assets | $83.88B | $82.15B | $81.66B | $78.95B |
Total Liabilities | $74.73B | $73.04B | $72.37B | $70.41B |
Cash & Equivalents | $1.59B | $1.54B | $1.73B | $1.54B |
Free Cash Flow OCF − CapEx | $595.00M | $1.22B | $1.26B | $2.26B |
Shares Outstanding | 511.11M | 544.28M | 561.73M | 566.00M |